Documentation Pain Management Practices Typically Request
Pain management and physical medicine groups considering a Wharton's jelly or exosome line commonly request a certificate of analysis for the specific lot, a donor eligibility summary, and confirmation of which regulatory framework applies to the product. Because exosome products are not FDA approved and are generally regulated as biologic drugs, many practices route that documentation to legal counsel separately from the orthopedic-style review used for cord tissue allografts.
Supplier characterization data for exosome products, where available, is provided to verified accounts on request rather than published as a marketing claim.
Columbia
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
122- Pain Medicine
- 77
- Physical Medicine & Rehabilitation
- 45
Physician and Medical Director Sign-Off
Because the determination of how a given intended use fits within applicable regulations rests with the practice and its counsel, Precision Biologics recommends that the supervising physician or medical director review product documentation before an order is placed, and confirm current standing with the South Carolina medical board as part of standard credentialing. Our role is limited to supplying documentation and specifications, not clinical or dosing guidance.
Shipping and Receiving in the Southeast
Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and are stored at -80 degrees Celsius before shipment; practices receiving shipments in Columbia should plan for same-day transfer into appropriate storage. Lyophilized exosome formats are shelf-stable under normal storage conditions, which some multi-site pain management groups prefer when back-office staff are not available every day to receive cold-chain packages.
Setting Up a Verified Account
New accounts require a valid NPI number tied to the ordering physician or practice. Once verified, accounts can request documentation, place orders, and reach our team for physician-level calls about product specifications. Multi-location pain management groups can register each site separately to keep lot traceability aligned with the correct NPI record.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can a pain management clinic in Columbia, SC order exosome products directly?+
Orders are limited to verified accounts held by licensed professionals with a valid NPI number. Exosome products are not FDA approved; purchase and use decisions rest with the practice and its own regulatory counsel.
What should a Columbia practice request before adding a new biologics line?+
A certificate of analysis, donor eligibility summary, and lot release record for the specific product, along with confirmation of the applicable regulatory framework.
How does Precision Biologics support account verification for Columbia clinics?+
We verify the NPI number against the NPPES registry, confirm the ordering physician, and provide a point of contact for documentation requests before the first order.